Truist Financial Corp Certara, Inc. Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	BUY	$13.36 - $18.94 $133 - $189	10 Added 0.07%	14,416 $199,000
Q1 2024 May 10, 2024	BUY	$15.65 - $19.45 $7,011 - $8,713	448 Added 3.21%	14,406 $257,000
Q4 2023 Feb 02, 2024	BUY	$12.12 - $18.19 $28,748 - $43,146	2,372 Added 20.47%	13,958 $245,000
Q3 2023 Nov 14, 2023	SELL	$13.9 - $19.58 $3,516 - $4,953	-253 Reduced 2.14%	11,586 $168,000
Q2 2023 Aug 01, 2023	SELL	$16.89 - $24.64 $77,204 - $112,629	-4,571 Reduced 27.85%	11,839 $215,000
Q1 2023 May 05, 2023	BUY	$15.9 - $24.72 $68,799 - $106,963	4,327 Added 35.81%	16,410 $395,000
Q4 2022 Feb 17, 2023	SELL	$10.7 - $17.84 $43,099 - $71,859	-4,028 Reduced 25.0%	12,083 $194,000
Q3 2022 Oct 26, 2022	SELL	$12.84 - $24.13 $2,349 - $4,415	-183 Reduced 1.12%	16,111 $214,000
Q2 2022 Jul 22, 2022	BUY	$16.75 - $22.54 $272,924 - $367,266	16,294 New	16,294 $350,000

232

105M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.79B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.